MMSI Form 144: 2,433 shares sold on NASDAQ via Morgan Stanley

Rhea-AI Filing Summary

Merit Medical Systems (MMSI) submitted a Form 144 reporting a proposed sale of 2,433 common shares, with an aggregate market value of $206,535.91. The shares are listed on NASDAQ and the filing shows 59,219,117 shares outstanding for the issuer, indicating the position sold is a very small fraction of the company’s total shares. The securities were acquired and are being sold on 08/11/2025 as a result of a stock option exercise, and payment was in cash. The sale is to be executed through Morgan Stanley Smith Barney LLC, Executive Financial Services at 1 New York Plaza, New York.

The filing indicates Nothing to Report for securities sold in the past three months. The provided content does not identify the named seller or filer CIK in the visible text. The notice includes the standard attestation that the seller does not possess undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale from an option exercise; amount is immaterial relative to outstanding shares, so market impact is likely neutral.

The filing reports a proposed sale of 2,433 common shares valued at $206,535.91, acquired and sold on 08/11/2025 via stock option exercise and paid in cash. The broker is disclosed as Morgan Stanley Smith Barney LLC. With 59,219,117 shares outstanding, the position disclosed is a very small portion of the capital base. There are no reported sales in the prior three months. From a market perspective, this appears to be a routine liquidity event rather than a material change to ownership or capitalization.

Corporate Governance Expert

TL;DR: Form 144 filing shows compliance with Rule 144; key transactional details are present but the seller identity is not visible in the provided text.

The form documents the mechanics of the transaction: acquisition by stock option exercise, immediate sale via a registered broker, and cash payment. The filing contains the required seller attestation regarding material nonpublic information. The visible content does not show the filer CIK or the named account holder, which are details often included elsewhere in the full filing. Overall, the disclosure meets the core requirements shown here and suggests a standard, compliant insider transaction.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2433	206535.91	59219117	08/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/11/2025	Stock Option Exercise	Issuer			2433	08/11/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Merit Medical (MMSI) shares are being sold under this Form 144?

The filing reports a proposed sale of 2,433 common shares.

What is the aggregate market value of the MMSI shares in this filing?

The aggregate market value is reported as $206,535.91.

When were the shares acquired and how were they acquired?

The shares were acquired on 08/11/2025 through a stock option exercise.

Which broker is handling the sale of MMSI shares?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services at 1 New York Plaza, New York.

On which exchange will the MMSI shares be sold?

The filing lists the sale as occurring on NASDAQ.

Were any MMSI securities sold by this person in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.